Aster DM Quality Care Limited DCF Valuation
ASTERDM · Healthcare · Current price ₹675
Aster DM Quality Care Limited cash-flow valuation
Our discounted cash flow (2-stage) values Aster DM Quality Care Limited at ₹87 per share. implied value is <0.2× the price (likely a data error). A discounted cash flow is only as good as the cash-flow path it assumes, so the assumptions behind it are listed in full below.
Try your own assumptions
Prefer to build the discounted cash flow yourself? The DCF calculator below opens pre-filled with Aster DM Quality Care Limited's reported free cash flow, net debt and share count, so you can set your own growth and discount rate.
How we got this fair value
Every number below is part of the same estimate for Aster DM Quality Care Limited. Nothing here is a target price or a forecast of where the share price will go.
Workable, with real gaps. Weigh it alongside your own view rather than on its own.
Estimate range ₹175 – ₹214
Why this method for this business
The relative P/E model is appropriate for a healthcare provider with a strong brand and consistent earnings, while DCF captures the intrinsic value of the business given its stable cash flows and capital-light operations.
The models behind the number
Each method is weighted by how well its inputs held up for this company.
implied value is <0.2× the price (likely a data error)
- ev_ebitda is not suitable for a healthcare provider with high capital expenditures and intangible assets
- relative_pe is more relevant than other multiples for a business with a durable moat and stable earnings
What was missing
- Lack of forward-looking analyst estimates for certain periods
- Limited data on capital expenditures and intangible assets
What drives it
16 inputs, grouped by how strong each claim is
- Sector-median P/E
- 64.99×
- Peers used
- 5
- EPS (TTM)
- 6.15 ₹/share
- Own-history median P/E
- 21.36×
peer-median
peer-median
computed
reconstructed (one feature, dampened — not a cap)
- Anchor correction
- peer anchor 65.0x diverges 0.3x from 9yr own-history 21.4x (no size-comparable peer) — anchor blended 0.6 toward own-history → 38.8x
- Term: quality
- -13.6%
- Term: growth
- -2.6%
- Term: capital_allocation
- +6.8%
- Term: financial_strength
- +3.7%
- Term: history
- -13.5%
- Term: sector_rerating
- +0.0%
- Term: rate_regime
- +1.2%
- Term: risk
- +0.0%
peer-anchor mismatch — deep own-history used instead
quality 28/100 (weak/erratic returns) → discount
weak ~4% CAGR (ROCE 7% < 12% hurdle (growth not value-accretive)) → discount
capital allocation: rising ROCE funded by strong FCF → premium
financial strength: low leverage (D/E 0.3) → mild premium
history: market paid -45% vs sector, dampened ×0.3 (one feature, not the anchor)
sector re-rating: no sector-norm history → not used
rates: risk-free 6.9% below ~7.1% normal → higher multiple
risk: no analyst-dispersion signal available → neutral (lowers confidence, not PE)
- Premium vs sector
- -18.4%
- Fair-multiple confidence
- 72%
- Fair P/E
- 31.67×
fundamentals + macro (not capped at own history)
data completeness + term agreement
sector median × ∏(1+term) — Dynamic Fair Multiple
Who computed this
A language model (qwen3:8b) selects the valuation method and the judgement inputs for Aster DM Quality Care Limited: which models suit the business, the moat, the growth and margin assumptions. It does not produce the number. The fair value itself is computed in Python by a deterministic engine (version 2026.08.1) from those inputs, so the same inputs always give the same result and every figure above can be traced to a source.
Estimated 14 Sept 2026. Re-run as new financials and news arrive.
How we value stocks
We estimate what a business is worth from its own economics: cash flows, returns on capital, and a multiple justified by its quality, rather than from where the share price has been. A fair value estimate is a view, not a verdict, and it is only as good as the inputs listed above.
Read the full fair-value methodologyMore on Aster DM Quality Care Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.